The present invention relates to pharmaceutical compositions comprising roflumilast, acebrophylline and salts thereof. In particular, the present invention relates to solid oral modified-release compositions comprising roflumilast and acebrophylline or salts thereof. The present invention also provides methods of preparing such modified-release compositions and methods of treating inflammatory diseases or disorders using such combinations.